United States · FDA National Drug Code directory
Myalept
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10122-210_8b236f4c-7654-49fe-bca9-ab947b72a1fd
- Product NDC
- 10122-210
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- metreleptin
- Labeler
- Chiesi USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20150305
- Source listing expiry
- 20261231
Source-listed ingredients
- METRELEPTIN — 11.3 mg/2.2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (10122-210-02) / 2.2 mL in 1 VIAL, GLASS · 10122-210-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →